Have You Heard of Doximity?

Doximity (NYSE: DOCS) is an online network platform for medical professionals that went public last week and is trading up near 124% from its IPO price. Let’s take a brief look at the company and how it got where it is today. Doximity (NYSE: DOCS) is an online network platform for medical professionals that went public last week and is trading up near 124% from its IPO price. Let’s take a brief look at the company and how it got where it is today. [Wealth Daily logo] Have You Heard of Doximity? [Monica Savaglia Photo] By [Monica Savaglia]( Written Jun 29, 2021 Doximity (NYSE: DOCS) went public last week and the market is still raving about this new stock. The company was up 69% on the first day of trading from its IPO price of $26 per share. Doximity is being touted as the “LinkedIn for doctors” by the public. The company does describe itself as an online networking platform for medical professionals, so being called “LinkedIn for doctors” isn’t too far off. Its name is short for “doctors and proximity.” The company aims to connect medical professionals, aspiring doctors, and medical institutions under one platform. Doximity is based in San Francisco, California, and was founded back in 2010 by its current CEO, Jeff Tangney, along with Nate Gross and Shari Buck. Last Thursday, the company made its public debut on the New York Stock Exchange. It was able to close last week with a market capitalization near $10 billion, raising around $500 million in its IPO. Of course, this got the attention of many investors who wondered what Doximity is and why the company was surging on its public debut. Doximity wasn’t lumped into the list of billion-dollar tech companies. During its last funding round in 2014, the company was valued at under $400 million. Tangney said that because Doximity is profitable, it still hasn’t touched the $50 million it raised seven years ago. The company didn’t need the money it raised and didn’t need to have any more funding rounds over past seven years because it was making a profit. One SECRET Company to Buy Now At this moment, we are witnessing the next great technological shift. It will change the world as we know it... Because nearly every single gadget you own is going to be completely obsolete in a matter of months. I’ve uncovered the company that’s secretly pulling the strings through this whole development. [Click here and get the full report before it’s too late.]( Tangney said in an interview after ringing the bell at the NYSE: I did resist some of the Silicon Valley wisdom of, you need to go big, you need to hire 40 more salespeople and do all these things. He added: The reality of health care and our clients, who are very staid institutions, a lot of non-profits that have been around for 100 years, is that even if you lean in and hire tons of sales and marketing people, they’re not going to let you grow. Essentially, Tangney doesn’t believe that it would be worthwhile for Doximity to aim for massive growth if its target market accepts it. Most of the company’s revenue is earned from drugmakers. "According to Reuters, Doximity’s 1.8 million members represent 80% of U.S. doctors. Eighty percent of its revenue comes from advertisements paid by pharmaceutical companies and hospitals, with the remainder derived from recruiters and telehealth," Forbes reports. Doximity doesn’t quite fit that Silicon Valley mold, and maybe that’s a good thing. He also mentioned in the interview that the company isn’t inclined to pay for branding for the sake of building its profile. This could explain why the company has remained unknown to most investors and the investing world. Tangney believes that the best advertising has come from doctors who endorse Doximity’s product through their practitioner networks. Despite being low-key within the Silicon Valley world, Doximity has been able to stay profitable and maintain strong financials. Last fiscal year, it generated over $200 million in revenue and produced over $50 million in net income. Doximity’s platform for medical professionals has become one of the largest medical networking apps, with about 1.8 million members. Tangney aimed to fix the challenges that he noticed in the medical field. He found out through his many conversations with medical professionals that communication had become a huge barrier and that it's often stressful getting in touch with patients, other doctors, administrators, or recruiters. Strange Tech Will Kick-Start the 4th Industrial Revolution [twa electric glass finger]Take a look at this tiny little chip. It might be small, but according to PwC, this chip will soon kick-start "the fourth industrial revolution." And if you position yourself right, I expect you could have the chance to turn every $500 into exceptional gains of up to $131,600. [Click here to see the details of this historic opportunity.]( Tangney estimated that about 80% of communication in the industry “is done via snail mail and fax.” He commented that “software is indeed eating the world, but it kind of choked a little bit on health care.” And Doximity was created to bridge the gap and create a place to communicate. The demand was high and explains why Doximity serves more than 80% of U.S. physicians and over 90% of recent medical school graduates. Per Tangney, product development at Doximity has been centered around doctors and what they need, which explains why in the company’s IPO plans, Doximity decided to allocate 3.5 million shares of its IPO to doctors on the platform, which represented 15% of the offering. And with Doximity’s public debut success those doctors also made a decent amount of money from the company’s IPO. Doximity’s stock surged 115% in its first two days of trading. The value of shares owned by doctors increased from $91 million to over $195 million. Tangney had this to say about this decision: Physicians are sort of outsiders in the financial markets and business world. Yet in our life and world, they’re the insiders, they’re the people we care about most. We’d rather the shares go to them if there’s a pop than to some hedge fund somewhere. Doximity cares about what it’s doing and cares about its platform's users. It isn’t interested in hyping up its business into something that it isn’t. Health care accounts for 18% of the U.S. economy, so there will always be room for Doximity to make money as long as it can keep its values and continue to expand and offer valuable features to its users. If you are interested in staying ahead and updated on companies like Doximity and their IPOs and news on the IPO market, [click here to stay up to date.]( Until next time, [Monica Savaglia Signature Park Avenue Digest] Monica Savaglia --------------------------------------------------------------- This Zero-Emission Fuel Will Lead the Next Energy Revolution Whether you believe in climate change or not, there will be a shift in discovering new and reliable energy. You see, the forest fires spreading on both the west AND east coasts are disrupting our energy supply. In fact, the source of 23% of America’s energy is dying. By the end of 2021, coal energy capacity will expire in 1.05 million homes. And if nothing’s done to halt this crisis, 67.8 million Americans could ultimately be left without power. Remember the deadly Texas power outage in February 2021? That only affected 5 million Americans. Think about the damage the loss of coal energy will cause. It’s such an important issue that finding a solution to our energy crisis is something both President Biden and former President Trump agree on. Fortunately, that solution might finally be within arm’s reach. There’s been a breakthrough in quantum technology that could lead us into a renewable energy revolution. I’m calling it “TriFuel-238.” A rod of this fuel no bigger than 35 nickels can power your home for up to 15 years. It’s 40,835 times more powerful and 67,389 times more potent than gasoline. Not to mention it’s 49.6% cheaper than coal and 17.9% cheaper than natural gas! But you must act quickly and get in on the ground floor of this power play. You could be one of the early investors pocketing a windfall of as much as 46,018%. [Click here now to get all the details.]( Browse Our Archives [The Key to an Electric Future]( [This Is Why the EV Is Doomed]( [How the Rich Stay Rich]( [3 Powerful Market Indicators Are Flashing "BUY" for This One Stock]( [The Demand for Cybersecurity Sets the Tone for SentinelOne’s IPO]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Wealth Daily, please add newsletter@wealthdaily.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Wealth Daily](, Copyright © 2021, [Angel Publishing LLC](. All rights reserved. 3 E Read Street Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Wealth Daily as well as a link to www.wealthdaily.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Wealth Daily]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.